MERS, SARS and other coronaviruses as causes of pneumonia

By Yu-dong Yin, R. Wunderink. Respirology (Carlton South. Print), 2017

1,097 citations recorded by the source corpus.

Human coronaviruses (HCoVs) have been considered to be relatively harmless respiratory pathogens in the past. However, after the outbreak of the severe acute respiratory syndrome (SARS) and emergence of the Middle East respiratory syndrome (MERS), HCoVs have received worldwide attention as important pathogens in respiratory tract infection. This review focuses on the epidemiology, pathogenesis and clinical characteristics among SARS‐coronaviruses (CoV), MERS‐CoV and other HCoV infections.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/453c5321985b60510b07949856f0d59f5504a3fd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis (2020, background): “Although the clinical picture of SARS, MERS, and COVID-19 seems to be similar, differences were noted [4,5,21,28] since early reports.”
From SARS to MERS, Thrusting Coronaviruses into the Spotlight (2019, background): “Unlike some other beta-coronaviruses, the MERS-CoV genome does not encode a hemagglutinin-esterase (HE) protein [1].”
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths (2020, background): “The direct cause of death is generally due to ensuing severe atypical pneumonia [4,5].”
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China (2020, neutral): “By 26 February 2020, the ongoing outbreak had caused a total of 78 497 confirmed infected cases and 2744 deaths in China, subsequently leading to a pandemic involving more than 70 countries.(5) In the COVID-19 crisis, cancer patients are regarded as a highly vulnerable group.”
Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China (2020, neutral): “3% COVID-19 patients in this study [13, 14].”
Rfam 14: expanded coverage of metagenomic, viral and microRNA families (2020, background): “RNA viruses are often highly contagious and can lead to fast-emerging severe diseases (21).”
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China (2020, neutral): “Before the first outbreak of SARS, a limited number of HCoVs such as HCoV-229E were frequently found to infect humans, and were widely circulating in human populations causing only mild illnesses like the common cold [3, 25] .”
COVID-19 and comorbidities: Deleterious impact on infected patients (2020, background): “(13%), which induced severe symptoms [3].”